Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy
Clinical trial NCT05575986 · UNKNOWN
Trial details
- NCT number
- NCT05575986
- Sponsor
- Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.